Drug trials for Alzheimer’s & MCI, other studies seeking volunteers

Interested in volunteering for Alzheimer’s and related research? Find current clinical trials and studies by location, drug name, or other keyword with NIA’s newly updated search tool! Below are the newest listings. Click on the trial name for details, including contact information. Drugs for Alzheimer’s, MCI Study of Nasal Insulin to Fight Forgetfulness (SNIFF) (multiple sites) Apathy in Dementia Mythylphenidate Trial 2 (ADMET 2) (multiple sites) Bryostatin to Treat Severe Alzheimer’s Disease (multiple sites) The Depression and Memory Trial (Forth Worth, TX) LY3002813 for Mild Cognitive Impairment or Alzheimer's Disease (multiple sites) NGP 555 in Healthy Volunteers (Cypress, CA) Sargramostim to Treat Mild Cognitive Impairment (Houston, TX) Biomarkers/Brain Imaging Cognitive Detection of Preclinical Alzheimer’s: Validation Using Biomarkers(New York, NY) Other Dementias Rehabilitation and Prevention of Word-Finding Problems in Primary Progressive Aphasia (Washington, DC, and Baltimore, MD) RVT-101 for Dementia with Lewy Bodies (Chapel Hill, NC, and Columbus, OH) Age-Related Cognitive Decline Mindfulness-Based Stress Reduction, Health Education, and Exercise (San Diego, CA, and St. Louis, MO) Registries GeneMatch (nationwide)—enroll to get matched to Alzheimer’s genetics studies Alzheimer’s Prevention Registry (nationwide)—get information and updates about participating in future Alzheimer’s prevention trials. Brain Health Registry (nationwide)—sign up for an online study of brain health and learn about possible research-study opportunities. Get more information about these and other Alzheimer’s clinical trials. Or, call the ADEAR Center at 1-800-438-4380 (toll-free) or email adear@nia.nih.gov. Help us spread the word about Alzheimer’s and related clinical trials! Forward this email to anyone who may be interested. Share via social media: Looking for #Alzheimer’s and related #clinicaltrials? Find the latest information here:  http://1.usa.gov/Y1zmEN